Carcinoid tumormetastatic to the orbit is a rare occurren ce. Wereport such a case in a patient with a carcinoidmetastasis that was found in the medial rectus mu scle. The dia gnosis was established via a transnasal endoscopic approach. We also discuss the treatment of meta static orbital carcinoid in the hop e that we will increase awareness of the utility oftransnasal endoscopy in fa cilitating both the dia gnosis and treatment ofposteromedial orbital pathology.
Introduction
Carcinoid tumors are slowly growing, potentially malignant neoplasms that arise from wherever endodermally derived neuroendocrine cells are found. The term carcinoid dates back to 1907 , when Oberndorfer used it to describe a tumor whose cell s exhibit a seemingly benign biologic behavior but are histologically similar to carcinoma cells.' It was not until several decades later that the malignant potential of these tumors became apparent.
Approximately 90 % ofcarcinoid tumors originate in the gastrointestinal tract ; other locations of particular interest to otolaryngologists include the middle ear, parotid gland, larynx, and thyroid gland. l" Orbital and ocular involvement by metastatic carcinoid is very rare . We describe a case in which the carcinoid tumor wa s metastatic to the medial rectus muscle. The diagnosis was made possible by endoscopic techniques. The purpose of this article is to increase awareness among otolaryngologists of the utility ofthe transnasal endoscopic approach in facilitating the diagnosis and treatment of posteromedial orbital pathology.
Case report
A 58-year-old woman presented to her ophthalmologist with a 6-week history of epi sodic vision loss in the right eye and a 2-week history of increasing photophobia and right-sided retro-orbital pressure. Further inquiry revealed a l-year history of fortification spectra acros s her visual field, and a 3-month history of paroxysmal vertex headaches radiating down the right side of her head in the distribution ofthe ophthalmic and maxillary divisions of the ipsilateral trigeminal nerve. Her medical history was remarkable for metastatic carcinoid of the liver, which had been diagnosed I year earlier by liver biopsy. She had undergone cycles of cisplatin, mitomycin C, and doxorubicin intra-arterially to induce remission of her hepatic disease.
The patient was also experiencing episodic facial flushing and dyspnea suggestive of carcinoid syndrome, which provided a further impetus for a metastatic workup . The workup included a bone scan, echocardiogram, and an indium III C11In) octreotide scan. Radiolabeled octreotide is a somatostatin analog that is highly sensitive in detecting carcinoid tumors, and it identified an asymptomatic depo sit in the lower lobe of the right lung, possibly indicating that this was the site of the primary tumor.
On ophth almologic examination, the patient's visual acuity in the right eye was 20/25 , and the intraocular tension was normal. Restricted abduction was noted on the right , causing diplopia on lateral gaze. Fundoscopy revealed optic disk edema, but no afferent pupillary defect was seen. There was no ptosis or proptosis. Computed tomography (CT) of the orbit identified a 1.7 x 2.5-cm dumbbell-shaped mass in the right medial rectus muscle (figure I).The mass extended to the orbital apex and displaced the optic nerve superiorly and laterally. Prominent scalloping of the lamin a papyracea was visible , but there was no bony erosion or evidence of intracranial extension.
The patient's ophth almic surgeon obtained a biopsy specimen via a right anterior orbitotomy. Unfortunately, not enough tissue was available to allow for a diagnosi s, so the patient subsequently underwent a transnasal tran sethmoid endoscopic biopsy and limited orbital decompression (figure 2). Following a stand ard endo scopic middle maxil- lary antrostomy and total ethm oidectomy, the ipsil ateral lamina papyracea wa s removed. The orbital perio steum was incised over the readil y visible mass, and repre sentative tumor samples were obtained.
Grossly, the tumor mass was pink-white, multilobular, soft, and friable. Infiltration of the medial rectu s muscle fibers was readily apparent. Metast atic orbital carcinoid was diagnosed. Histologic examination revealed nests of small , coh esive cell s with uniform nuclei , speckled chromatin, and indistinct or absent nucleoli typical ofcarcinoid tumors ( figure 3 ). Immunostains demonstrated uniform cytoplasmic ex pression of synaptophysin and chromogranin, also characteristic of carcinoid tumors.
The patient' s vision improved immediately after the procedure, only to progressively fade and become gradually darker over the following several weeks. Attempts to halt this progression with oral prednisone were unsuccessful, and repeat CT of the orbits revealed no change in the appearance of the mass. At 9 months' follow-up , the patient had completed 4,400 cGy of radiation to the right orbit , which produced a sma ll decrease in the CT appearance of the tumor and mild clin ical improvement in her sense of light perception. She was maintained on IllIn octreotide scanning to treat symptoms of associated carcinoid syndrome and cycles of palli ative ca pecitabine chemotherapy. At 2-year follow-up , the patient was stilI alive with metastatic carcinoid.
Discussion
The orbit can host a gre at variety of primary and secondary neopl asms. The medi al hemiorbit, defined as the area medial to the optic nerve, accounts fo r one-third of all orbit al neoplasms. Within this area , a similarly large variety of possible pathologies can ex ist, but hem angioma, dermoid, and pleomorphic adenoma tend to occur in the lateral orbit. 158 A patient's age and sex can help develop a differential diagnosis in the case of a space-occupying lesion in the medial orbit. For example, children tend to be affected by rhabdomyosarcoma or opt ic nerve glioma, whereas the elderly are more likel y to present with lymphoma or exp ansile sinus carcin oma. Women are more likely to pre sent with meningioma or meta static brea st adenocarcinoma, whereas men are more likely to present with carcinoma.
Metastatic lesion s account for 3 to 9% of all orbital tumors , with metastatic brea st adenocarcinoma being the most common." Carcinoid tumors metastasizing to the ocular structures or orbit are rare. When they do occur, they are nearly twice as common in women than men .?
All carcinoids are slowly growing, potentially malignant tumors. The most common site of origin is the appendix, followed by the ileum and bronchus. Being of neuroendocrine origin, carcinoid tumors can be nonfunctional or hormonally functional , and they can give rise to a variety Carci noid tumors are histo log ically charac ter ized by nests ofce lls with uniform sma ll nuclei, indistinc t nucleol i, and infrequ ent mitoses separated by delicate fibrous stroma . Cy top lasmic neurosecretory gra nules are highl ight ed by imrnunostains for synaptophysin and chromogranin . Th e pathologic differential diagnosis includes other metast atic neuroendocrin e tum ors (aty pic al carci noid, pulmonary small-ce ll carcinoma, and Merkel cell carc inoma) , metastatic mel anom a, sinonasal small-ce ll undifferent iated carci noma, olfac tory neuroblastoma, and paragangliom a. Retinoblastom as and metastatic neuroblastomas, altho ugh histologically similar to carc inoid, pri mari ly affect children.
Excludin g metastases to the globe, only 26 cases of metastasi s to the orbit have bee n previously reporte d in the literatu re (table).7.9-23 Carcinoid metastases to the ocular struc tures or orbit usuall y spread from a primary in the midgut. ' Th e less commo n bronchial carcinoids , which have a higher rate of metastas is, are more likely to spread to the uveal struc tures of the eye .
In view of the fact that so few cases have been repo rted, no con sensus exists on the appro pria te management of metastatic orbital carcino id. Patients with orbital meta stases have displayed a wide range of surv ival outco mes (table) .Th is fact shou ld be con side red when choo sing from Volume 86 , Number 3 amo ng the therapeutic optio ns for patient s with metastatic ca rcinoid. Surgery is recommend ed for smaller orbital metastases, bu t the role of cura tive surgery for larger lesions is undefined. Th e results of radiotherapy are less enco uraging than the result s of surgery, although patient selection bias might have played a role in the poor surviv al rates assoc iated with rad iation. Th e role of chemo therapy is unp roven. Som atostatin analogs such as octreotide are used for symptomatic relief of sympto ms associ ated with carc inoid syndrome . Finally, enucleation or orbital exenteration is generally reserve d for larger tumors that are unresponsive to other therapeut ic modalities.
Tradi tional surgical ap proac hes to the medial orbit are familiar to otolary ngologis ts, as this route is commonly used for drainage of subperiosteal abscesses, eth mo id artery ligation s for epistaxis, and vario us forms of maxi l-Iectorny. Exposure of medial lesion s near the orbital apex often requires detachin g the medial rectu s muscle from its scleral insertion or com bining the med ial approac h with a lateral orbitotorny. The latter techn ique is assoc iated with incre ased morbidity, and mos t externa l approaches req uire a concomi tant dacryocystorhinostom y (OC R). Use of the transcaruncular approach to the medial orbit would preclude the need for a OCR , but this approach is more fami liar to ophthalmic surgeons than to otolaryngologists."
Transnasal endosco py is another diag nostic and therapeutic optio n for the management of medial orbi tal lesion s. In our patient , the location of the mass in the posteromedial orbit made access via an externa l orbitotomy difficult. The transnasal endosco pic appro ach is idea lly suited for perform ing a biopsy of orbital lesions along the medial aspec t ofthe orbit, as first reported in the ophthalmology literature by Wein et al.? Thi s approach allows otolary ngo logis ts to biopsy a lesion for diagnostic purposes and to possi bly eve n remove a tumor to provide definitive treatment. Our decision to initially perform a biopsy on the orbital tumor was based on the intraoperati ve diagnostic uncertaint y posed by frozen-sec tion path ologic diagnosis and the fact that patients with carcinoid tumors have a high incidence of second prim ary malignant neoplasms .P:" Complete end oscopi c resection was an option, but not without sacrifice of the medi al rectus muscle and a further potential threat to the patient's vision. More "favorable" lesions, such as those appearing to be encapsulated, would be given greater consideration for immediate endo scop ic removal. Such a procedure in our patient was still an opt ion after pathologic confirmation and proper patient counseling regardin g vision risks. If a tumor is impinging on the opti c nerve posteriorly, the endosc opic approac h can be used for decompression purpo ses. Initially, our patient's vision was affected only minim ally, so limited decompression was performed by removing the bon y lamina.
Meta static orb ital carc inoid tumor represents only one of many diffe rent types of pathology in the medial orbit that the endoscopic surgeon potentially can diagno se or treat via a tran snasal approach. As for carcinoid tumors , the limited worldwide experience with them preclude s a general recommendation for complete rese ction in all case s.
To the best of our know ledge, ours is the first case reported in the otolaryngology literatur e of acarcinoid tumor metastatic to the orbit that dem onstrates the utility of a transnasal endo scopic approach in establishing a diagnosis of orbital carcinoid. The endoscopic approa ch is famili ar to otolaryngologists, and it prov ides us with relativ ely safe and direc t acce ss to the posteromedial orbit with minimal morbidity. It is our hope that otolaryngologists will keep this approach in mind for the diagno sis or treatment of posteromedial orbital pathology.
